Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133395) titled 'The Effect of Enhanced Intravenous Insulin Therapy on the Prognosis of Patients with Sepsis and a High Stress-Hyperglycemia Ratio' on Sept. 24.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Wuxi people's Hospital

Condition: stress-induced high blood sugar

Intervention: Insulin treatment group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Insulin treatment group:162;Control Group:162;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=338704

Published by HT Digita...